Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Extremely potent cytotoxic cryptophycin analogue discovered at Lilly

July 23, 1999

CDK2-inhibitory purine derivatives with potential in cancer therapy

July 23, 1999

UBCLE: a new protein discovered at Incyte; antagonists useful for cancer, etc.

July 23, 1999

Genta's BCL-2 antisense claims allowed in U.S.

July 23, 1999

Licensing opportunity from NIH: combination chemotherapy including a VIP antagonist

July 23, 1999

Molecular modeling yields new antiestrogenic and antitumor antineoplaston A10 analogues

July 22, 1999

Antisense oligonucleotides specific for TS mRNA sequences enhance FdUrd cytotoxicity

July 22, 1999

Water-soluble antitumor camptothecins reported by Japanese labs

July 22, 1999

Licensing opportunity from the NIH: immunotoxins directed against malignant B-cells

July 22, 1999

Targeted doxorubicin chemotherapy for liver cancer tested in phase I trial

July 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...